Northwest & Ethical Investments’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$316K Buy
12,244
+200
+2% +$4.73K 0.01% 449
2025
Q4
$320K Buy
12,044
+2,014
+20% +$43.9K 0.01% 438
2025
Q3
$173K Hold
10,030
﹤0.01% 470
2025
Q2
$125K Hold
10,030
﹤0.01% 464
2025
Q1
$119K Buy
10,030
+4,559
+83% +$62.2K ﹤0.01% 451
2024
Q4
$80K Sell
5,471
-900
-14% -$12.6K ﹤0.01% 455
2024
Q3
$80K Hold
6,371
﹤0.01% 474
2024
Q2
$54.2K Sell
6,371
-1,000
-14% -$8.9K ﹤0.01% 468
2024
Q1
$77.5K Buy
+7,371
New +$81.8K ﹤0.01% 455

Other funds holding ZYME

Northwest & Ethical Investments's ZYME Position: Q1 2026 in Review

Northwest & Ethical Investments increased its Zymeworks (ZYME) stake by 1.7% in Q1 2026, buying an estimated $4.73K and bringing the position to 12,244 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #449.

Northwest & Ethical Investments first reported a position in ZYME in Q1 2024 and has held it in 9 quarters since. The position peaked at $320K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Northwest & Ethical Investments held 12,244 shares of Zymeworks worth $316K as of Q1 2026.
  • Northwest & Ethical Investments bought 200 Zymeworks shares in Q1 2026, an estimated $4.73K.
  • Zymeworks made up 0.01% of Northwest & Ethical Investments's portfolio in Q1 2026, its #449 holding.
  • Northwest & Ethical Investments first reported a position in Zymeworks in Q1 2024 and has held it in 9 quarters since.
  • Northwest & Ethical Investments's Zymeworks position peaked at $320K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Northwest & Ethical Investments's 13F filing for Q1 2026, filed 14 May 2026.